Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
300.76
+6.12 (2.08%)
At close: May 12, 2025, 4:00 PM
292.31
-8.45 (-2.81%)
After-hours: May 12, 2025, 4:08 PM EDT
Madrigal Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Madrigal Pharmaceuticals stock have an average target of 420.63, with a low estimate of 350 and a high estimate of 469. The average target predicts an increase of 39.86% from the current stock price of 300.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Madrigal Pharmaceuticals stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 3 | 5 |
| Buy | 6 | 6 | 6 | 6 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $441 → $458 | Strong Buy | Maintains | $441 → $458 | +52.28% | May 2, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $422 → $460 | Strong Buy | Reiterates | $422 → $460 | +52.95% | May 2, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $394 → $420 | Strong Buy | Maintains | $394 → $420 | +39.65% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $443 | Buy | Reiterates | $443 | +47.29% | Apr 24, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $378 → $469 | Strong Buy | Maintains | $378 → $469 | +55.94% | Feb 27, 2025 |
Financial Forecast
Revenue This Year
656.67M
from 180.13M
Increased by 264.55%
Revenue Next Year
1.10B
from 656.67M
Increased by 67.21%
EPS This Year
-12.93
from -21.90
EPS Next Year
1.31
from -12.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 827.8M | 1.4B | 2.2B | ||
| Avg | 656.7M | 1.1B | 1.8B | ||
| Low | 477.7M | 805.1M | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 359.5% | 110.9% | 100.4% | ||
| Avg | 264.5% | 67.2% | 64.8% | ||
| Low | 165.2% | 22.6% | 5.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.00 | 19.70 | 46.42 | ||
| Avg | -12.93 | 1.31 | 23.70 | ||
| Low | -20.79 | -14.41 | -4.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 3,445.0% | ||
| Avg | - | - | 1,710.2% | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.